| RNA-Seq analysis in MeV EA Howe, R Sinha, D Schlauch, J Quackenbush Bioinformatics 27 (22), 3209-3210, 2011 | 501 | 2011 |
| Mev: multiexperiment viewer E Howe, K Holton, S Nair, D Schlauch, R Sinha, J Quackenbush Biomedical informatics for cancer research, 267-277, 2010 | 266 | 2010 |
| Biomedical informatics for cancer research E Howe, K Holton, S Nair, D Schlauch, R Sinha, J Quackenbush, MF Ochs, ... Biomedical Informatics for Cancer Research. Boston, MA: Springer US, 267-277, 2010 | 113 | 2010 |
| Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States AM Fisher, D Schlauch, M Mulloy, A Dao, AI Reyad, M Correll, GJ Fromell, ... Clinical Transplantation 35 (4), e14216, 2021 | 61 | 2021 |
| Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19. AE SA, A Junglen, JS Restivo, M Wongskhaluang, C Martin, P Doshi, ... The Journal of Clinical Investigation, 2021 | 47* | 2021 |
| Estimating drivers of cell state transitions using gene regulatory network models D Schlauch, K Glass, CP Hersh, EK Silverman, J Quackenbush BMC systems biology 11, 1-10, 2017 | 19 | 2017 |
| Estimating gene regulatory networks with pandaR D Schlauch, JN Paulson, A Young, K Glass, J Quackenbush Bioinformatics 33 (14), 2232-2234, 2017 | 19 | 2017 |
| Next-generation sequencing of patients with breast cancer in community oncology clinics EG Sturgill, A Misch, R Lachs, CC Jones, D Schlauch, SF Jones, ... JCO Precision Oncology 5, 1297-1311, 2021 | 17 | 2021 |
| Identification of genetic outliers due to sub-structure and cryptic relationships D Schlauch, H Fier, C Lange Bioinformatics 33 (13), 1972-1979, 2017 | 17 | 2017 |
| Discordance in tumor mutation burden from blood and tissue affects association with response to immune checkpoint inhibition in real-world settings EG Sturgill, A Misch, CC Jones, D Luckett, X Fu, D Schlauch, SF Jones, ... The Oncologist 27 (3), 175-182, 2022 | 15 | 2022 |
| Tumor-specific and tumor-agnostic molecular signatures associated with response to immune checkpoint inhibitors D Schlauch, X Fu, SF Jones, HA Burris III, DR Spigel, J Reeves, ... JCO Precision Oncology 5, 1625-1638, 2021 | 12 | 2021 |
| An online notebook resource for reproducible inference, analysis and publication of gene regulatory networks M Ben Guebila, D Weighill, CM Lopes-Ramos, R Burkholz, RT Pop, ... Nature methods 19 (5), 511-513, 2022 | 6 | 2022 |
| Adoption and utilization of NGS-based molecular profiling in community-based oncology practices: Insights from Sarah Cannon. A McKenzie, D Schlauch, Y Sharma, DR Spigel, HA Burris, SF Jones, ... Journal of Clinical Oncology 37 (15_suppl), e18064-e18064, 2019 | 6* | 2019 |
| The Network Zoo: a multilingual package for the inference and analysis of gene regulatory networks M Ben Guebila, T Wang, CM Lopes-Ramos, V Fanfani, D Weighill, ... Genome Biology 24 (1), 45, 2023 | 5 | 2023 |
| Next-generation sequencing (NGS) results among hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC … EP Hamilton, VM Jansen, EN Nash Smyth, D Schlauch, G Cuyun Carter, ... Journal of Clinical Oncology 37 (15_suppl), 1042-1042, 2019 | 3 | 2019 |
| De novo EGFR T790M mutations in a community-based oncology practice. ME Holt, A Misch, SK Rao, E Sturgill, C Jones, D Schlauch, D Luckett, ... Journal of Clinical Oncology 40 (16_suppl), 3146-3146, 2022 | 2 | 2022 |
| A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2− early breast cancer in the United States J Brown, S Scardo, M Method, D Schlauch, A Misch, S Picard, E Hamilton, ... BMC cancer 22 (1), 502, 2022 | 2 | 2022 |
| Development of a real-time risk model (RTRM) for predicting in-hospital COVID-19 mortality D Schlauch, AM Fisher, J Correia, X Fu, C Martin, A Junglen, HA Burris, ... medRxiv, 2021.04. 26.21256138, 2021 | 2 | 2021 |
| Techniques for generating investigatory-event mappings using graph-structure trajectories N O'connor, MA Correll, KH McGill, L Connors, D Schlauch US Patent 10,558,709, 2020 | 2 | 2020 |
| Treatment patterns, resource utilization and clinical outcomes in patients with higher risk myelodysplastic syndromes (MDS) in United States community practices SA Egloff, X Cao, R Lachs, C Martin, M Mattlin, E Fennell, D Rayburn, ... Leukemia & Lymphoma 64 (13), 2101-2112, 2023 | 1 | 2023 |
